Department of Urology, Southwest Jiaotong University Medical College, Affiliated Hospital of Southwest Jiaotong University, Chengdu Third People’s Hospital, Chengdu ?????, China
Abstract：Prostate biopsy is the gold standard for diagnosing prostate cancer. In clinical practice, elevated prostate specific antigen （PSA） or abnormal digital rectal examination （DRE） have been used as the criteria for transrectal ultrasound guided prostate biopsy （TRUS-GB）, but may lead to overdiagnosis and overtreatment of low-grade and clinically insignificant tumors, which brings physical, psychological and economic pressure to patients. Today there are many options for prostate biopsy, but a standard of prostate biopsy has not yet been established. This article reviews the general evolution of prostate biopsy technology from the most primitive finger-guided aspiration to the latest image fusion-targeted aspiration.
[1] World Cancer Report: Cancer Research for Cancer Prevention[EB/OL]. (2020-06-20). https://publications.iarc.fr/586. [2] 叶定伟, 朱耀. 中国前列腺癌的流行病学概述和启示[J]. 中华外科杂志,2015,53(4):249-252. [3] Latest global cancer data： cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020[EB/OL]. (2020-12-15). https://www.iarc.fr/faq/latest-global-cancerdata-2020-qa/. [4] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会前列腺癌诊疗指南[M] .北京:人民卫生出版社,2021:27-30. [5] THOMPSON J E, MOSES D, SHNIER R, et al.Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study[J]. J Urol,2014,192(1):67-74. [6] APPLEWHITE J C, MATLAGA B R, MCCULLOUGH D L, et al.Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer[J]. Cancer Control,2001,8(2):141-150. [7] ONUR R, LITTRUP P J, PONTES J E, et al.Contemporary impact of transrectal ultrasound lesions for prostate cancer detection[J]. J Urol,2004,172(2):512-514. [8] HODGE K K, MCNEAL J E, TERRIS M K, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate[J]. J Urol,1989,142(1):71-74; discussion 74-75. [9] CHING C B, MOUSSA A S, LI J, et al. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates[J]. J Urol,2009,181(5):2077-2082; discussion 2082-2083. [10] STAMEY T.Making the most out of six systematic sextant biopsies[J]. Urology,1995,45(1):2-12. [11] MCNEAL JE.Origin and evolution of benign prostatic enlargement[J]. Urol,1977,15:340-345. [12] JONES J.Prostate cancer: are we over-diagnosing- or under-thinking[J]? Eur Urol,2008,53(1):33-44. [13] ABRAHAM N E, MENDHIRATTA N, TANEJA S S.Patterns of repeat prostate biopsy in contemporary clinical practice[J]. J Urol,2015,193(4):1178-1184. [14] BORGHESI M, AHMED H, NAM R, et al.Complications after systematic, random, and image-guided prostate biopsy[J]. Eur Urol,2017,71(3):353-365. [15] GUO L H.Comparison between Ultrasound Guided Transperineal and Transrectal Prostate Biopsy:A Prospective,Randomized,and Controlled Trial[J].Sci Rep,2015,5:16089. [16] NELSON A W, HARVEY R C, PARKER R A, et al.Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy[J]. PLoS One,2013,8(2):e57480. [17] KASSON M, ORTMAN M, GAITONDE K, et al.Imaging prostate cancer using multiparametric magnetic resonance imaging: past, present, and future[J]. Semin Roentgenol,2018,53(3):200-205.
